Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

26.43 +2.96 (+12.59%)
Streaming Delayed Price Updated: 11:40 AM EDT, Mar 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 55,754,206
Open 23.12
Bid (Size) 26.42 (200)
Ask (Size) 26.44 (300)
Prev. Close 23.47
Today's Range 22.81 - 27.22
52wk Range 13.74 - 70.43
Shares Outstanding 191,922,517
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Short Seller Who Bet Against Hims & Hers Now Says Its CEO 'Wiped The Floor' With Novo Nordisk ↗
Hunterbrook had shorted Hims in 2024, warning its GLP-1 strategy relied on a regulatory loophole during drug shortages and could face legal risks tied to patents. 
Via Stocktwits
Topics Bankruptcy Fraud Intellectual Property
News headline image
3 Big Reasons to Love Hims & Hers Health (HIMS)
Hims & Hers Health has gotten torched over the last six months - since September 2025, its stock price has dropped 55.2% to $23.21 per share. This may have i... 
Via StockStory

Performance

YTD
-20.9%
-20.9%
1 Month
+36.7%
+36.7%
3 Month
-33.6%
-33.6%
6 Month
-44.7%
-44.7%
1 Year
-23.3%
-23.3%

More News

Read More
News headline image
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
From Hims & Hers
Via Business Wire
News headline image
Asset Manager Exits Shares of Hims & Hers Health ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Patience Pays: Hims & Hers Surges on News of Novo Nordisk Deal ↗
Via MarketBeat
News headline image
Disrupting the Pharmacy: A Deep-Dive into Hims & Hers Health (HIMS) in 2026
Via Finterra
Topics Artificial Intelligence Economy
News headline image
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
From Hims & Hers
Via Business Wire
From Red to Green: How Trump's Iran Endgame Sparked a Wall Street Comeback ↗
Via Chartmill
Topics Government
News headline image
HIMS Stock Rockets To Best Day Ever After Novo Nordisk Pact — Wall Street Upgrades Roll In As Shorts Lose $546M In One Day ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Stock Market Today, March 9: Hims & Hers Health Soars on Novo Nordisk Weight-Loss Drug Deal ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit Stocks
Top stock movements in today's session. ↗
Via Chartmill
These stocks are making the most noise in today's session. ↗
Via Chartmill
News headline image
The Great 2026 Pivot: Tangible Assets Surge as Tech Giants Falter in Massive Sector Rotation
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!
Via AB Newswire
Monday's session: top gainers and losers ↗
Via Chartmill
News headline image
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy? ↗
Via The Motley Fool
Topics Lawsuit
News headline image
Hims & Hers Stock Pops 40%: Everything You Need to Know ↗
Via The Motley Fool
Topics Lawsuit
News headline image
Why Hims & Hers Health (HIMS) Stock Is Up Today
Via StockStory
Topics Economy Lawsuit Stocks
Gapping stocks in Monday's session ↗
Via Chartmill
News headline image
The Pivot to Legitimacy: Hims & Hers Health (HIMS) Faces a New Era of Personalized Medicine
Via Finterra
Topics Artificial Intelligence Economy
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Hims & Hers Announces Strategic Shift for US Weight Loss Business
From Hims & Hers
Via Business Wire

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?
Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.
What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?
Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?
The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange
What is the current price of Hims & Hers Health, Inc. Class A Common Stock?
The current price of Hims & Hers Health, Inc. Class A Common Stock is 26.43
When was Hims & Hers Health, Inc. Class A Common Stock last traded?
The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 03/11/26 11:40 AM ET
What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?
The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 5.07B
How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?
Hims & Hers Health, Inc. Class A Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.